The company recorded nearly 15% decline in Agchem Exports due to global agrochemical industry contraction. Despite a 3% volume growth, domestic revenue softened by 9% YoY in Q4 FY26. During the period under review, Pharma revenue grew by 23% YoY and account for nearly 8% of the total export earnings.

While EBITDA contracted by 26% YoY to Rs 337.3 crore, EBITDA margin dropped by 402 basis points YoY to 22% in Q4 FY26.

Accordingly, profit before tax in Q4 FY26 stood at Rs 300.5 crore in Q4 FY26, down by 30% from Rs 432.2 crore in Q4 FY25.

For FY26, the company has recorded consolidated net profit and revenue from operations of Rs 1,320.8 crore (down 20% YoY) and Rs 6,713.7 crore (up 16% YoY), respectively.

PI Industries operates in the domestic agricultural inputs and custom synthesis manufacturing (CSM) exports segments. It is a leading player in the domestic agricultural inputs sector, primarily dealing in agrochemicals and plant nutrients.